Arjun Ghosh, MBBS, MSc, PhD, FHEA, FACC, FESC, FRCP, FICOS, University College London Hospitals, London, UK, discusses a recent publication on the evolving cardiac biomarkers for immune checkpoint inhibitor (ICI)-related myocarditis in cancer patients treated with ICIs, commenting on the feasibility of frequently monitoring these biomarkers in patients. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.